{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:42:09Z","timestamp":1778067729424,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.neurobiolaging.2004.01.005","type":"journal-article","created":{"date-parts":[[2004,3,12]],"date-time":"2004-03-12T10:20:40Z","timestamp":1079086840000},"page":"1315-1321","source":"Crossref","is-referenced-by-count":160,"title":["The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human \u03b2-amyloid precursor protein transgenic mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Joo-Yong","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzchak","family":"Angel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Young","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB1","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1074\/jbc.273.21.12817","article-title":"Dramatic aggregation of Alzheimer A\u03b2 by Cu(II) is induced by conditions representing physiological acidosis","volume":"273","author":"Atwood","year":"1998","journal-title":"J. Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0361-9230(85)90153-4","article-title":"Peptides and the blood\u2013brain barrier: lipophilicity as a predictor of permeability","volume":"15","author":"Banks","year":"1985","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1021\/js980302n","article-title":"Synthesis, stability, and pharmacological evaluation of nipecotic acid prodrugs","volume":"88","author":"Bonina","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.8073293","article-title":"Rapid induction of Alzheimer A\u03b2 amyloid formation by zinc","volume":"265","author":"Bush","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB5","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.96.24.14088","article-title":"Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid","volume":"96","author":"Calhoun","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB6","doi-asserted-by":"crossref","first-page":"23223","DOI":"10.1074\/jbc.274.33.23223","article-title":"Aqueous dissolution of Alzheimer\u2019s disease A\u03b2 amyloid deposits by biometal depletion","volume":"274","author":"Cherny","year":"1999","journal-title":"J. Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper\u2013zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer\u2019s disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB8","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1073\/pnas.96.4.1716","article-title":"Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene","volume":"96","author":"Cole","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB9","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-\u03b2 peptides differentially affect neuronal viability","volume":"277","author":"Dahlgren","year":"2002","journal-title":"J. Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/10611860008997913","article-title":"Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer\u2019s disease","volume":"8","author":"Deguchi","year":"2000","journal-title":"J. Drug Target"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JAD-2001-3206","article-title":"The severity of cortical Alzheimer\u2019s type changes is positively correlated with increased amyloid-\u03b2 levels: resolubilization of amyloid-\u03b2 with transition metal ion chelators","volume":"3","author":"Fonte","year":"2001","journal-title":"J. Alzheimer Dis"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0270(87)90042-2","article-title":"A quinoline fluorescence method for visualizing and assaying the histochemically reactive zinc (bouton zinc) in the brain","volume":"20","author":"Frederickson","year":"1987","journal-title":"J. Neurosci Methods"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1023\/A:1015803922401","article-title":"Enhanced delivery of 5-iodo-2\u2032-deoxyuridine to the brain parenchyma","volume":"9","author":"Ghosh","year":"1992","journal-title":"Pharm Res"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.297.5585.1260","article-title":"New Alzheimer\u2019s treatments that may ease the mind","volume":"297","author":"Helmuth","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB15","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.1237107100","article-title":"Spherical aggregates of \u03b2-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I\/glycogen synthase kinase-3\u03b2","volume":"100","author":"Hoshi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB17","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1021\/bi990438f","article-title":"The A\u03b2 peptide of Alzheimer\u2019s disease directly produces hydrogen peroxide through metal ion reduction","volume":"38","author":"Huang","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB18","doi-asserted-by":"crossref","first-page":"37111","DOI":"10.1074\/jbc.274.52.37111","article-title":"Cu(II) potentiation of Alzheimer\u2019s A\u03b2 neurotoxicity: correlation with cell-free hydrogen peroxide production and metal reduction","volume":"274","author":"Huang","year":"1999","journal-title":"J. Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid-\u03b2 protein in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB21","doi-asserted-by":"crossref","unstructured":"Kozak A, Shapiro I. Lipophilic diesters of chelating agents. Int Pat Publ 1999;WO 99\/16741.","DOI":"10.1145\/301136.301252"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB22","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1074\/jbc.M007859200","article-title":"Comparative analysis of amyloid-\u03b2 chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer\u2019s disease brains","volume":"276","author":"Kuo","year":"2001","journal-title":"J. Biol Chem"},{"issue":"RC10","key":"10.1016\/j.neurobiolaging.2004.01.005_BIB23","first-page":"1","article-title":"Histochemically reactive zinc in plaques of the Swedish \u03b2-amyloid precursor transgenic mice","volume":"19","author":"Lee","year":"1999","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB24","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1073\/pnas.092034699","article-title":"Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB25","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1021\/bi990205o","article-title":"Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A\u03b2 peptide of Alzheimer\u2019s disease","volume":"38","author":"Liu","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB26","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1073\/pnas.91.25.12243","article-title":"\u03b2-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red","volume":"91","author":"Lorenzo","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB28","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB29","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","article-title":"Neurodegeneration induced by \u03b2-amyloid peptides in vitro: the role of peptide assembly state","volume":"13","author":"Pike","year":"1993","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev.neuro.21.1.479","article-title":"Mutant genes in familial Alzheimer\u2019s disease and transgenic models","volume":"21","author":"Price","year":"1998","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000051288","article-title":"Treatment of Alzheimer\u2019s disease with clioquinol","volume":"12","author":"Regland","year":"2001","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0891-5849(00)00494-9","article-title":"Redox-active iron mediates amyloid-\u03b2 toxicity","volume":"30","author":"Rottkamp","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1471-4159.2000.0740270.x","article-title":"In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease: a central role for bound transition metals","volume":"74","author":"Sayre","year":"2000","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB34","doi-asserted-by":"crossref","first-page":"A23","DOI":"10.1038\/19866","article-title":"Translating cell biology into therapeutic advances in Alzheimer\u2019s disease","volume":"399","author":"Selkoe","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/ana.410420612","article-title":"Amyloid \u03b2-protein deposition in the leptomeninges and cerebral cortex","volume":"42","author":"Shinkai","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm0196-93","article-title":"Presence of soluble amyloid \u03b2-peptide precedes amyloid plaque formation in Down\u2019s syndrome","volume":"2","author":"Teller","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB37","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0002-9440(10)64644-5","article-title":"Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons","volume":"157","author":"Van Dorpe","year":"2000","journal-title":"Am J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7085","article-title":"The levels of soluble versus insoluble brain A\u03b2 distinguish Alzheimer\u2019s disease from normal and pathologic aging","volume":"158","author":"Wang","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9440(10)65616-7","article-title":"Amyloid \u03b2 accumulates in putative interstitial fluid drainage pathways in Alzheimer\u2019s disease","volume":"153","author":"Weller","year":"1998","journal-title":"Am J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB40","doi-asserted-by":"crossref","first-page":"12676","DOI":"10.1073\/pnas.94.23.12676","article-title":"Ultrastructural localization of zinc transporter-3 (ZnT-3) to synaptic vesicle membranes within mossy fiber boutons in the hippocampus of mouse and monkey","volume":"94","author":"Wenzel","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2004.01.005_BIB41","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1046\/j.1432-1327.2000.01767.x","article-title":"Examining the zinc binding site of the amyloid-\u03b2 peptide","volume":"267","author":"Yang","year":"2000","journal-title":"Eur J. Biochem"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458004000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458004000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T18:22:02Z","timestamp":1550168522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458004000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0197458004000430"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.01.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}